Johnson & Johnson has just released its Q2 figures showing sales fell back in the second quarter, a 3.5% growth …

Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

